The latest news about the CMCiB. For more news of research at the IGTP, please see our main website.
Time is Brain, Spin-off company from the IGTP, closes its financing round in little more than an hour
The seed-funding round for the IGTP Spin-off Time is Brain has reached its financing objective in record time almost as soon as it opened. The company opened the round on the platform Capital Cell and has not only reached the goal of 640,000, but has passed it and received 800,000, the figure the spin-off had set as a maximum.
Biomaterial scaffolds containing extracellular vesicles from stem cells to control and promote heart muscle repair after heart attack
Scientists of the ICREC group at the Germans Trias i Pujol Research institute (IGTP) continue to refine their technology for repairing cardiac tissue after a heart attack. In a paper published in Bioactive Materials they present their latest work in which they use implanted scaffolds containing no cells, but extracellular vesicles that promote the repair of myocardium damaged in a heart attack.
The CMCiB contributes to a new e-book on researcher and animal safety
A new e-book published by the Journal Laboratory Equipment, called Safe and Effective Research in the Vivarium features a case study from the Centre for Comparative Medicine and Bioimage of the IGTP (CMCiB-IGTP). Staff from the CMCiB have provided expert advice on aspects of safety.
Mireia Ramos Rodríguez is awarded the prize for the Best Research Paper by a Predoctoral Student by the Catalan Institute of Health
Mireia Ramos Rodríguez is a bioinformatics post-doctoral researcher; she focusses on defining the changes in cis-regulatory elements that can lead to the development of disease and programming to provide tools for other researchers to carry out their analyses. She has been awarded the Prize for Best Research Paper in Health by a Predoctoral Researcher for her article published in Nature Genetics.
The first projects on SARS-CoV-2 in lab-designed mini human organs gets underway
The Centre for Comparative Medicine and Bioimage of Catalonia (CMCiB), of the Germans Trias i Pujol Research Institute (IGTP), will be the second centre in Catalonia to work on the SARS-CoV-2 virus obtained directly from patients. Until now most work has taken place with artificial viruses that can only infect once. Research staff of IrsiCaixa and the Institute of Evolutionary Biology (IBE) have started to work on the virus in the CMCiB to study the infection of organoids; mini organs designed in the laboratory to simulate human lungs and brains. Organoids are already being used in research and their use in studies into COVID-19 will provide better understanding of infection by SARS-CoV-2 and the capacity of different drugs to eliminate it from these tissues.
A new paper shows how the CMCiB will shine a new light on neurobiology
A review paper with first author Marc Melià-Sorolla of the Cellular and Molecular Neurobiology Research Group and published in the International Journal of Molecular Sciences highlights a porcine model as the most suitable for stroke research in the future. The CMCiB-IGTP is equipped to carry out this type of research and the group led by Teresa Gasull are already showing the potential of the non-invasive bioimaging technology.